For your kind perusal, please find attached the WG4 Proposed Document 'Guidelines for Adverse Event Reporting of Percutaneous Coronary Intervention (PCI) devices for the Medical Device Manufacturer or its Authorized Representative'.

Kindly send your comments with the template attached to the GHWP Secretariat (secretariat@ghwp.info) on or before 2 September 2024 (Monday) 12:00noon (GMT+8). Thank you.